Official filing · 20034025
Thomas H Kean congressional stock disclosure
Thomas H Kean filed a public congressional financial disclosure on February 19, 2026. CopyGov shows 6 extracted transactions, including 1 purchase involving $ABT, $GM, $JNJ, $MKL, $MSFT, with a link to the original House record.
FiledFebruary 19, 2026
Transactions extracted6
Purchases / sales1 / 5
Extraction statusparsed
Reported transactions
| Asset | Ticker | Type | Transaction date | Reported owner | Reported value |
|---|---|---|---|---|---|
| Abbott Laboratories Common Stock (ABT) | $ABT | purchase | 2026-01-29 | self | $1,001 to $15,000 |
| General Motors Company Common Stock (GM) | $GM | sale | 2026-01-07 | self | $1,001 to $15,000 |
| Johnson & Johnson Common Stock (JNJ) | $JNJ | sale | 2026-01-23 | self | $15,001 to $50,000 |
| Markel Group Inc. Common Stock (MKL) | $MKL | sale | 2026-01-23 | self | $15,001 to $50,000 |
| Microsoft Corporation - Common Stock (MSFT) | $MSFT | sale | 2026-01-23 | self | $1,001 to $15,000 |
| Stryker Corporation Common Stock (SYK) | $SYK | sale | 2026-01-23 | self | $15,001 to $50,000 |
How to cite this filing
CopyGov canonical record
https://copygov.com/filings/20034025
Original government record
https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034025.pdf
Record checked 2026-09-15T07:25:55.807Z. Public dataset available through 2026-09-14.
A filing records reported transactions. It is not a complete current portfolio. The reported owner may be the filer, a spouse, a dependent or a joint account. Filing and transaction dates are different. Confirm extracted details in the official PDF before publication or investment use.